Chronic News and Research

RSS

BioScrip announces revenues of $341.6M for fourth-quarter

BioScrip, Inc. today announced fourth quarter revenues of $341.6 million and net income of $40.7 million, or $0.99 per diluted share, which includes the reversal of the Company’s deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with BioScrip’s pending acquisition of Critical Homecare Solutions, Inc. and $4.3 million of incentive compensation expense relating to the Company’s employee compensation program.

26 Feb 2010

Community-wide wellness initiative to deliver preventive health care services to northwest Arkansas

U.S. Preventive Medicine® and Washington Regional Medical Center, together with Arkansas Occupational Health Clinic and Kids for Health, today introduced an initiative to deliver preventive health care services to northwest Arkansas. This community-wide wellness initiative aims to save lives and money by keeping Arkansans healthy and treating chronic illnesses before they progress.

26 Feb 2010

Canadian nurses remind federal government ahead of its budget: Health and wealth go hand in hand

Canadian nurses are reminding the federal government ahead of its March 4 budget that health and wealth go hand in hand, with a healthy workforce being a crucial element of economic recovery.

26 Feb 2010

HIMSS10 Interoperability Showcase: Initiate Systems to offer full roster of activities for fifth consecutive year

At the HIMSS10 Conference and Exhibits March 1 – 4, Initiate Systems, Inc., a leader in health information sharing, will offer a full roster of activities that includes exhibits, product demonstrations, customer presentations and, for the fifth consecutive year, participation in the HIMSS10 Interoperability Showcase.

26 Feb 2010

Heel pain continues to be the most common reason patients seek care, say foot and ankle surgeons

If you are suffering from heel pain, you're not alone. According to foot and ankle surgeons attending the 68th Annual Scientific Conference of the American College of Foot and Ankle Surgeons in Las Vegas this week, heel pain continues to be the most common reason patients seek care. Surgeons advise the best defense to keeping pain in control is early treatment.

26 Feb 2010

Surgeons perform nation's first incision-free myotomy procedure to treat achalasia

Surgeons at UC San Diego Medical Center have performed the nation's first incision-free myotomy, a procedure to treat achalasia, a distressing disorder which causes difficulty swallowing, regurgitation and chest pain. The innovative surgery, performed through the mouth, is the most recent in a series of groundbreaking clinical trial surgeries being evaluated by the UCSD Center for the Future of Surgery.

26 Feb 2010

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

The Hartford Courant: "With average rate hikes at 13 percent or more this year for most plans, Connecticut health insurance premiums appear to be rising faster than the nation's. A typical family plan in Connecticut sold through an employer costs about $14,500 -- an estimate based on the Kaiser Family Foundation's report on 2009 prices and this year's rates of growth.

25 Feb 2010

New research using MRI shows that childhood stress can lead to structural brain changes

New research using magnetic resonance imaging (MRI) shows that childhood stress such as abuse or emotional neglect, in particular when combined with genetic factors, can result in structural brain changes, rendering these people more vulnerable to developing depression. The study led by scientists at Trinity College Dublin has just been published in the international scientific journal, Neuropsychopharmacology.

25 Feb 2010

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for its newest product, the Glider™ balloon catheter, for percutaneous transluminal angioplasty (PTA) of lesions in the peripheral vasculature including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries.

25 Feb 2010

Translational Regenerative Medicine Forum in Winston-Salem

A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem.

25 Feb 2010

Semafore Pharmaceuticals awarded U.S. patent covering PI-3 kinase inhibitor prodrugs

Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled “PI-3 Kinase Inhibitor Prodrugs.” This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore’s clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.

25 Feb 2010

HealthGrades America’s 50 Best Hospitals for 2010 identified

The HealthGrades America’s 50 Best Hospitals for 2010 were identified in a report issued today by the leading independent healthcare ratings organization. The analysis, which examined objective patient outcomes over three years at all 5,000 of the nation’s nonfederal hospitals, found that the 50 Best Hospitals had mortality rates that were, on average, 27% lower than other hospitals.

25 Feb 2010

Signaling molecules may link certain actions of B cells to solid tumor growth: Study

Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.

25 Feb 2010

NIH panel proposes multiple management strategies for lactose intolerant individuals

Lactose intolerance is a real and important clinical syndrome, but quantifying its public health burden is challenging. An NIH Consensus Development panel was convened this week to assess the available evidence on lactose intolerance and health across the age spectrum and across racial and ethnic groups.

25 Feb 2010

Study examines how individuals utilize benefits and services under Medicare program

Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.

25 Feb 2010

Study: People can reduce their sensitivity to pain by thickening their brain

People can reduce their sensitivity to pain by thickening their brain, according to a new study published in a special issue of the American Psychological Association journal, Emotion. Researchers from the Universit- de Montr-al made their discovery by comparing the grey matter thickness of Zen meditators and non-meditators.

25 Feb 2010

A surgical cure for diabetic and obese patients

Dr. Francesco Rubino, chief of gastrointestinal metabolic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is now enrolling overweight and mildly obese patients -- those with a body mass index (BMI) of 28 to 35 -- in a study of gastric bypass surgery aimed at reversing Type 2 diabetes.

25 Feb 2010

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

MicroTransponder, Inc., a privately-held medical device company, has just announced a $7 Million Series B round of funding. MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications.

25 Feb 2010

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Fisher Wallace Laboratories today announced that two psychiatry professors at Columbia University, Dr. Richard Brown and Dr. Andres San Martin, have prescribed the Fisher Wallace Cranial Stimulator to more than 250 patients suffering from depression, anxiety and insomnia.

25 Feb 2010

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

A study by researchers in Australia and the United Kingdom suggests that autoantibodies to fat binding proteins significantly increase in systemic lupus erythematosus (SLE) patients with active disease. This increase in anti-apolipoprotein (anti-Apo A-I), anti-high-density lipoprotein (anti-HDL), and anti-C-reactive protein (anti-CRP) may contribute to the development of atherosclerosis in SLE patients, placing them at risk for cardiovascular disease (CVD).

25 Feb 2010

Chronic News and Research

BioScrip announces revenues of $341.6M for fourth-quarter

Community-wide wellness initiative to deliver preventive health care services to northwest Arkansas

Canadian nurses remind federal government ahead of its budget: Health and wealth go hand in hand

HIMSS10 Interoperability Showcase: Initiate Systems to offer full roster of activities for fifth consecutive year

Heel pain continues to be the most common reason patients seek care, say foot and ankle surgeons

Surgeons perform nation's first incision-free myotomy procedure to treat achalasia

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

New research using MRI shows that childhood stress can lead to structural brain changes

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

Translational Regenerative Medicine Forum in Winston-Salem

Semafore Pharmaceuticals awarded U.S. patent covering PI-3 kinase inhibitor prodrugs

HealthGrades America’s 50 Best Hospitals for 2010 identified

Signaling molecules may link certain actions of B cells to solid tumor growth: Study

NIH panel proposes multiple management strategies for lactose intolerant individuals

Study examines how individuals utilize benefits and services under Medicare program

Study: People can reduce their sensitivity to pain by thickening their brain

A surgical cure for diabetic and obese patients

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News